About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zoetis (NY: ZTS )

175.04 -1.11 (-0.63%)
Streaming Delayed Price Updated: 10:11 AM EST, Nov 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zoetis

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
15 16 Next >
Zoetis' Osteoarthritis Med for Dogs Set to Deliver Significant Advantages In 2024, Analyst Says
Friday, the FDA approved Zoetis Inc's (NYSE: ZTS) Librela (bedinvetmab) for the control of pain associated with  
Via Benzinga
Zoetis Announces U.S. FDA Approval of Librela™ (bedinvetmab injection) to Control Osteoarthritis (OA) Pain in Dogs
From Zoetis Inc.
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Zoetis (ZTS) Q1 2023 Earnings Call Transcript
ZTS earnings call for the period ending March 31, 2023. 
Via The Motley Fool
Zoetis Tumbles As Spot's Drugmaker Reports Mixed Earnings, Though Keeps Outlook
Zoetis says it still expects sales and earnings to grow in 2023. 
Via Investor's Business Daily
$1000 Invested In Zoetis 5 Years Ago Would Be Worth This Much Today
Via Benzinga
$100 Invested In Zoetis 5 Years Ago Would Be Worth This Much Today
Via Benzinga
$100 Invested In Zoetis 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Zoetis Announces First Quarter 2023 Results
From Zoetis Inc.
Via Business Wire
Earnings Scheduled For May 4, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss at $1.83 per share on revenue of $104.21 million. 
Via Benzinga
Zoetis Announces Date for 2023 Investor Day
From Zoetis Inc.
Via Business Wire
This Favorable Sign Appears On Zoetis's Chart
Via Benzinga
Zoetis Stock Shows Rising Relative Strength Upgrades
Zoetis shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 81. 
Via Investor's Business Daily
5 Women-Led Businesses Absolutely Crushing the Stock Market Right Now
The number of businesses led by women is growing every year. And as the results show, investors should embrace -- and invest in -- women-led companies. 
Via The Motley Fool
Why These 2 Vet Med Stocks Are Surging
The boom in pet adoptions during the pandemic will pay off for years for these companies. 
Via The Motley Fool
3 Pet Stocks That Could Purr in 2023 and Beyond
These three pet stocks are all worth a look, particularly by long-term investors seeking a sector with impressive growth catalysts. 
Via InvestorPlace
Zoetis Stock Shows Healthy Growth Along With Puppies, Kittens
Zoetis stock is trying to complete a flat base with a 176.76 buy point. See if it can break out. Its stock got an upgrade Monday 
Via Investor's Business Daily
Zoetis Foundation Announces First Round of 2023 Grants to Advance Farmer and Veterinarian Education, Livelihoods and Well-being
From Zoetis Inc.
Via Business Wire
3 Healthcare Stocks to Watch As the Industry Evolves
Healthcare stocks are often considered a safe investment due to the consistent demand for medical products and services. 
Via InvestorPlace
Zoetis to Host Webcast and Conference Call on First Quarter 2023 Financial Results
From Zoetis Inc.
Via Business Wire
Zoetis Stock Sees IBD Relative Strength Rating Improve To 73
Zoetis stock had its Relative Strength Rating upgraded to 73 Monday -- a nice improvement, but still shy of the 80-plus score you look for. 
Via Investor's Business Daily
Zoetis Named One of the World’s Most Ethical Companies by Ethisphere
From Zoetis Inc.
Via Business Wire
Zoetis to Participate in the TD Cowen Health Care Conference
From Zoetis Inc.
Via Business Wire
Zoetis Secures $15.3 Million Grant to Advance Sustainable Livestock Production and Improve Livelihoods in Sub-Saharan Africa
From Zoetis Inc.
Via Business Wire
Zoetis to Participate in the Bank of America Securities 2023 Animal Health Summit
From Zoetis Inc.
Via Business Wire
Arista Networks, Zoetis And This Airline Stock On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors named Zoetis Inc (NYSE: ZTS) as her 
Via Benzinga
3 Stocks to Avoid This Week
These investments seem pretty vulnerable right now. 
Via The Motley Fool
MarketBeat Week in Review – 2/13 - 2/17
Retail sales were up but so was inflation which meant more volatility for stocks. Enjoy your holiday weekend and catch up on our most read stories this week 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Why Zoetis Stock Shot Almost 9% Higher This Week
Robust net-income growth and better-than-expected guidance brought the bulls back to the animal health specialist. 
Via The Motley Fool
Zoetis, Pet-Med Specialist, Double-Digit Earnings Growth Ahead
Animal health company Zoetis is up 7.99% in the past week, after topping fourth-quarter views. Analysts see double-digit EPS growth in 2023 and 2024. 
Via MarketBeat
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.